Samvel B Gasparyan
17PUBLICATIONS
35CO-AUTHORS

Get your video featured.

Get your video featured.
Publications (17)
Sort by Publication Date:
|Apr 15, 2026
Response by Myte et al to Letter Regarding Article, "Survival Odds to Minimize Risk Heterogeneity Bias in Heart Failure Trials: Application to Dapagliflozin".Robin Myte, Samvel B Gasparyan, Per Nyström
|Feb 16, 2026
Characterizing Treatment Effects on Patient-Reported Outcomes in Heart Failure Trials.Robin Myte, Samvel B Gasparyan, Per Nyström
|Jan 26, 2026
A Hierarchical Composite Endpoint for Chronic Kidney Disease Progression in Patients with Focal Segmental Glomerulosclerosis.Hiddo J L Heerspink, Dustin J Little, Samvel B Gasparyan
|Oct 31, 2025
Survival Odds to Minimize Risk Heterogeneity Bias in Heart Failure Trials: Application to Dapagliflozin.Robin Myte, Andrea Mattsson, Matt Poole
|Jun 17, 2025
Use of eGFR Slope Thresholds as End Point Components in a Kidney Disease Progression Hierarchical Composite End Point.Niels Jongs, Samvel B Gasparyan, Lars Frison
Pageof 3
Frequent Collaborators
5 joint publications
Hiddo J L Heerspink
4 joint publications
Dustin J Little
4 joint publications
Niels Jongs
3 joint publications
Elaine K Kowalewski
3 joint publications
Robin Myte
3 joint publications
Martin Karpefors
3 joint publications
John J V McMurray
3 joint publications
Meike Brinker
2 joint publications
Mikhail N Kosiborod
2 joint publications
Pardeep S Jhund